Detailed information for compound 1743952

Basic information

Technical information
  • Name: Unnamed compound
  • MW: 753.838 | Formula: C38H51N5O11
  • H donors: 8 H acceptors: 11 LogP: 3.39 Rotable bonds: 28
    Rule of 5 violations (Lipinski): 4
  • SMILES: CC(C[C@@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)O)CC(C)C)CCC(=O)O)CCC(=O)O)NC(=O)[C@@H](NC(=O)c1ccccc1)Cc1ccccc1)C
  • InChi: 1S/C38H51N5O11/c1-22(2)19-28(42-37(52)29(21-24-11-7-5-8-12-24)41-33(48)25-13-9-6-10-14-25)36(51)40-26(15-17-31(44)45)34(49)39-27(16-18-32(46)47)35(50)43-30(38(53)54)20-23(3)4/h5-14,22-23,26-30H,15-21H2,1-4H3,(H,39,49)(H,40,51)(H,41,48)(H,42,52)(H,43,50)(H,44,45)(H,46,47)(H,53,54)/t26-,27-,28-,29-,30-/m0/s1
  • InChiKey: JHRSEXISQRPECO-IIZANFQQSA-N  

Network

Hover on a compound node to display the structore

Synonyms

No synonyms found for this compound

Targets

Known targets for this compound

No curated genes were found associated with this compound

Predicted pathogen targets for this compound

By orthology
No druggable targets predicted by orthology data
By sequence similarity to non orthologous known druggable targets
No druggable targets predicted by sequence similarity

Obtained from network model

Ranking Plot


Putative Targets List


Species Potential target Raw Global Species
Loa Loa (eye worm) hexokinase type II 0.0184 0.252 1
Onchocerca volvulus 0.0184 0.252 1
Plasmodium falciparum V-type K+-independent H+-translocating inorganic pyrophosphatase 0.0387 1 1
Loa Loa (eye worm) hexokinase 0.0184 0.252 1
Echinococcus multilocularis hexokinase 0.0184 0.252 0.5
Trypanosoma cruzi Vacuolar proton pyrophosphatase 1, putative 0.0387 1 1
Loa Loa (eye worm) hypothetical protein 0.0125 0.037 0.1468
Brugia malayi Hexokinase family protein 0.0184 0.252 1
Schistosoma mansoni hexokinase 0.0184 0.252 0.5
Plasmodium vivax V-type H(+)-translocating pyrophosphatase, putative 0.0387 1 1
Plasmodium falciparum V-type H(+)-translocating pyrophosphatase, putative 0.0387 1 1
Echinococcus granulosus hexokinase type 2 0.0184 0.252 0.5
Treponema pallidum hexokinase (hxk) 0.0184 0.252 0.5
Loa Loa (eye worm) hexokinase 0.0184 0.252 1
Entamoeba histolytica hexokinase 1 0.0184 0.252 0.5
Plasmodium vivax vacuolar-type H+ pumping pyrophosphatase, putative 0.0387 1 1
Echinococcus multilocularis hexokinase type 2 0.0184 0.252 0.5
Trypanosoma cruzi vacuolar-type proton translocating pyrophosphatase 1 0.0387 1 1
Echinococcus multilocularis hexokinase 0.0184 0.252 0.5
Toxoplasma gondii V-type H(+)-translocating pyrophosphatase VP1 0.0387 1 1
Trypanosoma brucei Pyrophosphate-energized vacuolar membrane proton pump 1 0.0387 1 1
Echinococcus granulosus hexokinase 0.0184 0.252 0.5
Brugia malayi hexokinase 0.0184 0.252 1
Echinococcus granulosus hexokinase 0.0184 0.252 0.5
Trypanosoma brucei Pyrophosphate-energized vacuolar membrane proton pump 2, putative 0.0387 1 1
Onchocerca volvulus 0.0184 0.252 1
Onchocerca volvulus 0.0184 0.252 1
Echinococcus granulosus hexokinase 0.0184 0.252 0.5
Echinococcus multilocularis hexokinase 0.0184 0.252 0.5
Entamoeba histolytica hexokinase 2 0.0184 0.252 0.5

Activities

Activity type Activity value Assay description Source Reference
Relative activity (functional) = 27 % Relative activity for inhibition of rat liver vitamin K dependent carboxylase mediated carboxylation of pentapeptide at 1 mM. ChEMBL. 7252980

Phenotypes

Whole-cell/tissue/organism interactions

We have no records of whole-cell/tissue assays done with this compound What does this mean?

Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.

Annotated phenotypes:

We have no manually annotated phenotypes for this drug. What does this mean? / Care to help?
In TDR Targets, information about phenotypes that are caused by drugs, or by genetic manipulation of cells (e.g. gene knockouts or knockdowns) is manually curated from the literature. These descriptions help to describe the potential of the target for drug development. If no information is available for this gene or if the information is incomplete, this may mean that i) the papers containing this information either appeared after the curation effort for this organism was carried out or they were inadvertently missed by curators; or that ii) the curation effort for this organism has not yet started.
 
In any case, if you have information about papers containing relevant validation data for this target, please log in using your TDR Targets username and password and send them to us using the corresponding form in this page (only visible to registered users) or contact us.

External resources for this compound

Bibliographic References

No literature references available for this target.

If you have references for this compound, please enter them in a user comment (below) or Contact us.